Company news

Microba Life Sciences Limited news in 2025

Microba Life Sciences Limited's news releases, calls and decks from 2025, newest first.

View company

Microba receives $3 million R&D Tax Incentive Refund

December 2, 2025

Q1 FY26 Quarterly Investor Presentation & Webinar

October 27, 2025

Q1 FY26 Quarterly Activities Report & Appendix 4C

October 27, 2025

2025 Annual Report & Appendix 4E

August 26, 2025

Q4 FY25 Quarterly Investor Presentation & Webinar

July 21, 2025

Q4 FY25 Quarterly Activities Report & Appendix 4C

July 21, 2025

Disclosure Document - Prospectus

June 27, 2025

Strategic Investment & Equity Raise Presentation

June 23, 2025

Reinstatement to Quotation

June 23, 2025

Microba secures $14.5 million to drive clinical adoption

June 23, 2025

Suspension from Quotation

June 23, 2025

Trading Halt

June 18, 2025

MetaPanel Pathogen Study Delivers Breakthrough Results

May 20, 2025

Microba Announces Landmark GI Study Results From Over 4,600 Patients

May 14, 2025

Landmark GI Study Results from over 4,600 patients

May 13, 2025

Q3 FY25 Quarterly Investor Presentation & Webinar

April 29, 2025

Q3 FY25 Quarterly Activities Report & Appendix 4C

April 29, 2025

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

April 29, 2025

Appendix 4D & FY25 Interim Report

February 25, 2025

Q2 FY25 Quarterly Investor Presentation & Webinar

January 28, 2025

Q2 FY25 Quarterly Activities Report & Appendix 4C

January 28, 2025

Calls in 2025

Decks in 2025